{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Laaboub N"],"funding":["Swiss National Science Foundation","GlaxoSmithKline foundation","GlaxoSmithKline foundation (GSK)"],"pagination":["1420-1430"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12916320"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["31(3)"],"pubmed_abstract":["Caffeine metabolic ratios (CMR) following monitored caffeine intake are the gold standard to probe cytochrome P450 (CYP) 1A2 activity, which metabolizes antipsychotics like clozapine and olanzapine. Given caffeine's ubiquity, we tested whether random CMR from dietary caffeine were associated with (1) clinical, genetic, and epigenetic factors linked to CYP1A2 activity; (2) plasma concentrations of clozapine and olanzapine; and (3) psychotropic treatment response. First, we analyzed two population-based studies (CoLaus|PsyCoLaus, N = 4898; SKIPOGH, N = 2054) to investigate random CMR associations with clinical, genome-wide, and epigenome-wide factors associated with CYP1A2 activity. Second, in psychiatric cohorts, we tested CMR associations with dose-normalized plasma concentrations (C/D) of"],"journal":["Molecular psychiatry"],"pubmed_title":["Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses."],"pmcid":["PMC12916320"],"funding_grant_id":["3200B0-118308","124087","3200B0–105993","3200B0-105993"],"pubmed_authors":["Conus P","Ponte B","Pruijm M","Petrovic D","Eap CB","Ranjbar S","Vandenberghe F","Vogt B","Preisig M","Ansermot N","Piras M","Crettol S","Strippoli MF","Bochud M","Vandenberghe-Durr S","von Gunten A","Pistis G","Vollenweider P","Laaboub N","Plessen KJ","Gamma F","Marques-Vidal P"],"additional_accession":[]},"is_claimable":false,"name":"Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses.","description":"Caffeine metabolic ratios (CMR) following monitored caffeine intake are the gold standard to probe cytochrome P450 (CYP) 1A2 activity, which metabolizes antipsychotics like clozapine and olanzapine. Given caffeine's ubiquity, we tested whether random CMR from dietary caffeine were associated with (1) clinical, genetic, and epigenetic factors linked to CYP1A2 activity; (2) plasma concentrations of clozapine and olanzapine; and (3) psychotropic treatment response. First, we analyzed two population-based studies (CoLaus|PsyCoLaus, N = 4898; SKIPOGH, N = 2054) to investigate random CMR associations with clinical, genome-wide, and epigenome-wide factors associated with CYP1A2 activity. Second, in psychiatric cohorts, we tested CMR associations with dose-normalized plasma concentrations (C/D) of","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Mar","modification":"2026-07-16T09:15:00.659Z","creation":"2026-07-09T10:46:20.398Z"},"accession":"S-EPMC12916320","cross_references":{"pubmed":["40962832"],"doi":["10.1038/s41380-025-03256-x"]}}